Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3671000001113 | lyophilisate.oromucosal | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 3681000001110 | lyophilisate.oromucosal ontology form and route (qualifier value) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 3691000001112 | lyophilisate.oromucosal ontology form and route | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lyophilisate.oromucosal ontology form and route | Is a | Ontology form and route | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Buprenorphine 2mg oral lyophilisates sugar free | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | True | lyophilisate.oromucosal ontology form and route | Inferred relationship | Existential restriction modifier | |
| Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | True | lyophilisate.oromucosal ontology form and route | Inferred relationship | Existential restriction modifier | |
| Buprenorphine 8mg oral lyophilisates sugar free | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | True | lyophilisate.oromucosal ontology form and route | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR